Colorado Springs, Colo.-based Spectranetics Corp., a single-use
medical device manufacturer, has announced its clinical trial plans related to the
treatment of in-stent restenosis in arteries above the knee. Currently, there are
no devices cleared or approved by the FDA to treat in-stent restenosis. The company
has planned to initiate a multicenter randomized trial in the US to compare laser
ablation followed by adjunctive balloon angioplasty with balloon angioplasty alone.
- laser ablation
- The removal of material from a surface by high intensity pulsed or CW laser radiation emission.
MORE FROM PHOTONICS MEDIA